Aprepitant and Vinorelbine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Aprepitant (aprepitant) and Vinorelbine (vinorelbine). Common drug interactions include neuropathy peripheral among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Aprepitant and Vinorelbine. It is created by eHealthMe based on reports of 65 people who take the same drugs from the FDA, and is updated regularly.

What is Aprepitant?

Aprepitant has active ingredients of aprepitant. eHealthMe is studying from 6,992 Aprepitant users. Check the latest studies of Aprepitant.

What is Vinorelbine?

Vinorelbine has active ingredients of vinorelbine. eHealthMe is studying from 6,381 Vinorelbine users. Check the latest studies of Vinorelbine.



On Jul, 19, 2026

65 people who take Aprepitant and Vinorelbine together, and have interactions are studied.

Aprepitant and Vinorelbine drug interactions.

What are the common drug interactions of Aprepitant and Vinorelbine, by gender? *:

female:

  1. Neuropathy peripheral (surface nerve damage)
  2. Constipation
  3. Cough
  4. Abdominal pain
  5. Lacrimation increased
  6. Oropharyngeal pain
  7. Weight decreased
  8. Urinary tract infection
  9. Alopecia (absence of hair from areas of the body)
  10. Depressed mood

male:

  1. Pneumonia
  2. Pulmonary embolism (blockage of the main artery of the lung)
  3. Colitis ulcerative (inflammation of colon with ulcer)
  4. Death
  5. Haemoglobin decreased
  6. Neoplasm progression (growth of tumour)
  7. Non-small cell lung cancer (type of epithelial lung cancer)

What are the common drug interactions of Aprepitant and Vinorelbine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Colitis ulcerative (inflammation of colon with ulcer)

50-59:

  1. Nausea (feeling of having an urge to vomit)
  2. Headache (pain in head)
  3. Diarrhoea
  4. Neuropathy peripheral (surface nerve damage)
  5. Constipation
  6. Abdominal pain
  7. Cough
  8. Lacrimation increased
  9. Oropharyngeal pain
  10. Weight decreased

60+:

  1. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
  2. Pneumonia
  3. Dyspnoea exertional (breathlessness or shortness of breath)
  4. Epistaxis (bleed from the nose)
  5. Headache (pain in head)
  6. Myalgia (muscle pain)
  7. Nausea (feeling of having an urge to vomit)
  8. Visual impairment
  9. Vomiting
  10. Haemoglobin decreased

What are the existing conditions these people have? *

  1. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 32 people, 49.23%
  2. Wheezing (a high-pitched whistling sound made while you breath): 31 people, 47.69%
  3. Muscle Spasms (muscle contraction): 31 people, 47.69%
  4. Breast Cancer: 31 people, 47.69%
  5. Heart Palpitations (feelings or sensations that your heart is pounding or racing): 31 people, 47.69%
  6. Muscle Twitching: 30 people, 46.15%
  7. Headache (pain in head): 30 people, 46.15%
  8. Constipation: 29 people, 44.62%
  9. Oropharyngeal Pain: 29 people, 44.62%
  10. Urinary Tract Infection: 29 people, 44.62%

* Approximation only. Some reports may have incomplete information.

Do you take Aprepitant and Vinorelbine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Aprepitant and Vinorelbine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Aprepitant:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Vinorelbine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aprepitant and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vinorelbine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on aprepitant and vinorelbine (the active ingredients of Aprepitant and Vinorelbine, respectively), and Aprepitant and Vinorelbine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: